Abstract
Defects in dysferlin gene cause limb-girdle muscular dystrophy 2B or Miyoshi distal myopathy. Nonsense mutations have been reported to be most common among Korean patients with dysferlinopathy. More than half of the patients have at least one nonsense allele in dysferlin. Readthrough by ataluren is a promising strategy to overcome nonsense mutation, in use for the nonsense-mediated Duchenne muscular dystrophy. We generated a knock-in mouse with p.Q832* mutation, most frequently found among our dysferlinopathy cases. Mice with homozygous p.Q832* mutation lost dysferlin expression at sarcolemma. It performed worse on the Rotarod and forelimb grip test than wild type C57BL6 mice and moved less on activity monitoring. On eccentric contraction ex vivo, extensor digitorum longus muscle from these mice tended to break easily. These abnormalities could successfully be alleviated when the mice were orally administered with ataluren in liquid. Furthermore, ataluren decreased the number of damaged muscle, fiber size variation and serum creatine kinase level. This results support that readthrough strategy with ataluren will also be applicable to patients with nonsense dysferlin mutation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.